Information  X 
Enter a valid email address

EPIC/TIDM matching '0Y3M'

Date
Time Source
Company
Announcement
06 Aug 2019 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports Second Quarter 2019 Financial Results and Provides R&D Update
30 Jul 2019 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Report Second Quarter 2019 Financial Results on August 6
01 Jul 2019 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Announces Appointment of Paula K. Cobb to its Board of Directors
30 May 2019 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Participate in the Jefferies Healthcare Conference
07 May 2019 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports First Quarter 2019 Financial Results and Provides R&D Update
30 Apr 2019 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Report First Quarter 2019 Financial Results on May 7
18 Apr 2019 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports Results from the Phase 3 VITAL Amyloidosis Study of NEOD001 (birtamimab) in AL Amyloidosis
05 Mar 2019 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Participate in Upcoming March Healthcare Conferences
14 Feb 2019 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports Fourth Quarter and Full Year 2018 Financial Results, and Provides Financial Guidance and R&D Update
04 Feb 2019 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Report Fourth Quarter and Full Year 2018 Financial Results and Host Webcast Conference Call on February 14
06 Nov 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports Third Quarter 2018 Financial Results and Provides R&D Update
30 Oct 2018 8:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Report Third Quarter 2018 Financial Results on November 6
07 Aug 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update
31 Jul 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Report Second Quarter 2018 Financial Results on August 7
25 Jun 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Announces Appointment of Tran B. Nguyen as Chief Operating Officer
19 Jun 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Announces Phase 1b Clinical Trial Results of PRX002/RG7935 for Parkinson's Disease Published in JAMA Neurology
24 May 2018 2:00 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Announces Reorganization to Focus Resources on Advancing Neuroscience Pipeline
08 May 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports First Quarter 2018 Financial Results and Provides R&D Update
01 May 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Report First Quarter 2018 Financial Results on May 8
23 Apr 2018 1:00 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Discontinues Development of NEOD001 for AL Amyloidosis
20 Mar 2018 8:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene for Novel Therapies for Patients with Neurodegenerative Diseases
12 Mar 2018 8:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Present a Broad Range of Scientific and Health Outcomes Data at the 16th International Symposium on Amyloidosis
07 Mar 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Participate in the Barclays Global Healthcare Conference
14 Feb 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports Fourth Quarter and Full Year 2017 Financial Results, and Provides Financial Guidance and R&D Update
07 Feb 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Participate in the Leerink Partners 7th Annual Global Healthcare Conference
02 Feb 2018 9:15 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Announces Departure of Chief Medical Officer
01 Feb 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Report Fourth Quarter and Full Year 2017 Financial Results and Host Webcast Conference Call on February 14
03 Jan 2018 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Participate in the 36th Annual J.P. Morgan Healthcare Conference
22 Nov 2017 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Participate in the Evercore ISI Biopharma Catalyst/Deep Dive Conference
16 Nov 2017 1:00 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Highlights Breadth of Novel Pipeline at R&D Day
07 Nov 2017 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports Third Quarter 2017 Financial Results and Provides R&D Update
01 Nov 2017 8:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Participate in the Credit Suisse 26th Annual Healthcare Conference
31 Oct 2017 8:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Report Third Quarter 2017 Financial Results on November 7
28 Sep 2017 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports Results from Phase 1b Multiple Ascending Dose Study of PRX003 in Patients with Psoriasis
15 Aug 2017 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Present New Research on Cardiac Biomarker NT-proBNP in AL Amyloidosis at HFSA Annual Meeting
08 Aug 2017 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports Second Quarter 2017 Financial Results and Provides R&D Update
01 Aug 2017 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Report Second Quarter 2017 Financial Results on August 8
05 Jul 2017 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Announces Initiation of Phase 2 PASADENA Study of PRX002/RG7935 in Patients with Early Parkinson's Disease
29 Jun 2015 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Announces Addition of Seasoned Executive to Board of Directors
17 Jun 2015 12:00 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Presents Clinical Results Demonstrating Robust, Rapid Reduction in Levels of Free Serum Alpha-Synuclein of Up to 96% After Single Dose of PRX002...
16 Jun 2015 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Present at JMP Securities Life Science Conference 2015 on June 23
12 Jun 2015 12:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena's NEOD001 Protein Immunotherapy Clinical Data Highlighted in Oral Presentation at the 20th Congress of the European Hematology Association
  12:00 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Opportunity to Improve Diagnosis and Treatment of Systemic Amyloidosis Highlighted in Patient Experience Survey Presented at the 20th Congress of the European Hematology Association
09 Jun 2015 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Announces First Human Dosed in Phase 1 Study of PRX003 for the Treatment of Psoriasis and Other Inflammatory Diseases
08 Jun 2015 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Present Clinical Results From Its Phase 1 Single Ascending Dose Study of PRX002 at 19th International Congress of Parkinson's Disease and Movement Disorders
02 Jun 2015 5:15 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Presents Compelling New Data From Ongoing Phase 1/2 Study of NEOD001 in Patients With AL Amyloidosis at 2015 ASCO Annual Meeting
21 May 2015 1:00 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Announces Presentation of Clinical Data From the Ongoing Phase 1/2 NEOD001 Study and Systemic Amyloidosis Patient Survey Results at 20th Congress of the European Hematology Association
13 May 2015 10:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Present Updated Clinical Data From Ongoing Phase 1/2 Study of NEOD001 at 2015 ASCO Annual Meeting
05 May 2015 9:25 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Reports First Quarter 2015 Financial Results and Provides R&D Update
04 May 2015 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) The Michael J. Fox Foundation and Prothena Partner to Accelerate Discovery of Novel Biomarkers for Parkinson's Disease
28 Apr 2015 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena to Present at Upcoming Investor Healthcare Conferences
23 Apr 2015 9:05 pm GNW   Factsheet Prothena Corporation plc (0Y3M) Dr. Dale Schenk to Participate on Expert Panel at World Medical Innovation Forum: Neurosciences
08 Apr 2015 11:00 am GNW   Factsheet Prothena Corporation plc (0Y3M) Prothena Announces Pricing of Public Offering of 3,300,000 Ordinary Shares
06 Apr 2015 9:07 pm GNW   Factsheet Prothena Corporation (0Y3M) Prothena Announces Proposed Offering of Ordinary Shares
19 Mar 2015 8:05 pm GNW   Factsheet Prothena Corporation (0Y3M) Prothena Reports Robust Reduction of Free Serum Alpha-Synuclein of up to 96% After Single Dose of PRX002, a Novel Protein Immunotherapy for Parkinson's Disease
05 Mar 2015 9:05 pm GNW   Factsheet Prothena Corporation (0Y3M) Prothena Reports Fourth Quarter and Full Year 2014 Financial Results and Provides 2015 Financial Guidance and R&D Update
19 Feb 2015 9:05 pm GNW   Factsheet Prothena Corporation (0Y3M) Prothena to Report Fourth Quarter and Full Year 2014 Financial Results and Host Webcast and Conference Call on March 5
18 Feb 2015 9:05 pm GNW   Factsheet Prothena Corporation (0Y3M) Prothena to Present at the 2015 RBC Capital Markets' Healthcare Conference in New York on February 25
15 Dec 2014 9:05 pm GNW   Factsheet Prothena Corporation (0Y3M) Prothena Receives FDA Fast Track Designation fo...


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t